MomeAllerg Nasenspray

MomeAllerg is a well-known over-the-counter nasal spray used primarily for the treatment of hay fever and allergic rhinitis symptoms. The active ingredient is mometasone furoate, a powerful corticosteroid that reduces inflammation in the nasal passages. This specific product is a prominent brand within the German pharmaceutical market, designed to provide 24-hour relief from nasal congestion, sneezing, and itching.

The brand is a key part of the portfolio of Hexal AG, a major German pharmaceutical company. Hexal was originally founded in 1986 and grew to become one of the leaders in the generic drug market. Today, the brand is owned by Sandoz, which was formerly a division of Novartis but completed its spin-off into an independent, publicly traded global leader in generic and biosimilar medicines in late 2023. Manufacturing for MomeAllerg typically occurs in Germany, adhering to strict European pharmaceutical standards.